Most Active InvestorsFind investorsBlogPricing
Start for free
Start for free
UBS Asset Management logo

UBS Asset Management

Europe, England, United Kingdom, London

Description

UBS Asset Management delivers to the UK market the extensive capabilities of a truly global organisation.

Investor Profile

UBS Asset Management has backed more than 9 startups, with 0 new investments in the last 12 months alone. The firm has led 2 rounds, about 22% of its total and boasts 4 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Private Equity, Series A rounds (top funding stages).
  • Majority of deals are located in United States, China, France.
  • Strong thematic focus on Biotechnology, Health Care, Therapeutics.

Stage Focus

  • Series B (22%)
  • Private Equity (22%)
  • Series A (22%)
  • Post Ipo Equity (11%)
  • Post Ipo Debt (11%)
  • Series C (11%)

Country Focus

  • United States (78%)
  • China (11%)
  • France (11%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Life Science
  • Medical
  • Pharmaceutical
  • Enterprise
  • Manufacturing
  • Business Intelligence
  • E-commerce
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does UBS Asset Management frequently co-invest with?

New Leaf Venture Partners
New Leaf Venture Partners
North America, New York, United States, New York
Co-Investments: 2
Alexandria Venture Investments
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 1
MPM Capital
MPM Capital
North America, Massachusetts, United States, Boston
Co-Investments: 5
Taiho Ventures
Taiho Ventures
North America, California, United States, California City
Co-Investments: 2
Cathay Capital
Cathay Capital
Europe, Ile-de-France, France, Paris
Co-Investments: 1
F2 Ventures
F2 Ventures
Europe, England, United Kingdom, London
Co-Investments: 2
Arix Bioscience
Arix Bioscience
Europe, England, United Kingdom, London
Co-Investments: 2
ArrowMark Partners
ArrowMark Partners
North America, Colorado, United States, Denver
Co-Investments: 1
6 Dimensions Capital
6 Dimensions Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1
CV
curative ventures
North America, Texas, United States, Dallas
Co-Investments: 1

Which angels does UBS Asset Management often collaborate with?

JH
Jonathan Huberman
North America, Texas, United States, Dallas
Shared Deals: 1

What are some of recent deals done by UBS Asset Management?

DFD

Jiaozuo, Henan, China

DFD is a high-tech enterprise engaged in the research, development, production and sales of high-performance inorganic fluorides.

EnterpriseManufacturing
Post Ipo EquityAug 17, 2023
Amount Raised: $274,672,453
Nogin

Tustin, California, United States

Nogin provides commerce solutions to optimize the entire e-commerce lifecycle for D2C brands.

Business IntelligenceE-CommerceInternetSoftware
Post Ipo DebtAug 30, 2022
Amount Raised: $60,000,000
REEF

Miami, Florida, United States

REEF Technology is a company that transforms urban real estate such as parking facilities into thriving mobility and logistical hubs.

AppsE-Commerce PlatformsFood DeliveryLast Mile TransportationParking
Private EquityNov 3, 2020
Amount Raised: $700,000,000
Altitude Infrastructure

Val-de-roulans, Franche-Comte, France

Altitude Infrastructure is a pioneer operator in the telecommunications infrastructure sector.

Telecommunications
Private EquitySep 17, 2020
Amount Raised: $592,346,878
Harpoon Therapeutics

South San Francisco, California, United States

Harpoon Therapeutics is a clinical-stage immunotherapy company focused on the development of novel T-cell recruiting biologic therapies.

BiotechnologyHealth CareTherapeutics
Series CNov 12, 2018
Amount Raised: $70,000,000
TCR2

Cambridge, Massachusetts, United States

TCR2 is a discovery stage pharmaceutical company that developed a unique proprietary TRuC™ platform.

BiotechnologyHealth CareLife ScienceMedicalPharmaceuticalTherapeutics
Series BMar 21, 2018
Amount Raised: $125,000,000
Harpoon Therapeutics

South San Francisco, California, United States

Harpoon Therapeutics is a clinical-stage immunotherapy company focused on the development of novel T-cell recruiting biologic therapies.

BiotechnologyHealth CareTherapeutics
Series BMay 25, 2017
Amount Raised: $45,000,000
TCR2

Cambridge, Massachusetts, United States

TCR2 is a discovery stage pharmaceutical company that developed a unique proprietary TRuC™ platform.

BiotechnologyHealth CareLife ScienceMedicalPharmaceuticalTherapeutics
Series ADec 8, 2016
Amount Raised: $44,500,000
Harpoon Therapeutics

South San Francisco, California, United States

Harpoon Therapeutics is a clinical-stage immunotherapy company focused on the development of novel T-cell recruiting biologic therapies.

BiotechnologyHealth CareTherapeutics
Series AApr 1, 2016
Amount Raised: $15,000,000

Find More Investors Like UBS Asset Management

Discover similar investors in our database and build your perfect investor list.

series_b InvestorsInvestors in LondonBrowse All InvestorsTop Investors

Need help with your fundraising strategy?Read our fundraising guides

Decorative background shape
Decorative background shape

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Most Active Investors Find InvestorsNewsletterPricing

Free tools

Pre-Money and Post-Money Valuation Calculator

Investors By Location

San FranciscoNew York CityBostonLos AngelesChicagoLondonParisIndiaSingaporeTel Aviv

Investors By Stage

Angel InvestorsPre-Seed InvestorsSeed InvestorsSeries A InvestorsSeries B InvestorsSeries C InvestorsSeries D Investors
UBS Asset Management | Pipeseed